Header image

Theme A Session 4: HIV Vaccines & Immunopathogenesis 1

Tracks
.
Tuesday, September 25, 2018
11:00 AM - 12:30 PM
Tuscan (Ground Floor)

Details

Learning Objectives: This session will cover both the advantages and weaknesses of the immune system in HIV. Presentations will explore immunological based prevention strategies that show promise for use in future vaccine strategies. In contrast, presentations will also cover HIV immunopathogenesis, where the immune system fails to control HIV

Speaker

Dr. Shelby O’Connor
Associate Professor
University Of Wisconsin-madison

The IL-15 superagonist ALT-803 enhances antiviral cellular immunity in macaques

11:00 AM - 11:20 AM

Audio Recording

Speaker Presentation

Biography

Prof Stephen Kent
Professor
Doherty Institute

Passive antibody imunity to prevent, control and cure HIV

11:20 AM - 11:40 AM

Biography

Katherine Ognenovska
Phd Candidate
Kirby Institute

Diaphanous Formin 1 Knockdown Disrupts Nuclear Localisation Of HIV-1 Latency-Inducing siRNA

11:40 AM - 12:00 PM

Abstract

Biography

Xiao Qian Wang
Masters Student
Westmead Institute For Medical Research

Full-Length Sequencing Of HIV Proviruses In HIV-HBV Co-Infected Individuals From Thailand

12:00 PM - 12:15 PM

Abstract

Biography

Mr Muhammad Jaeson
Student
Australian National University

Type 2 Innate Lymphoid Cells Induced Following Viral Vector-Based Vaccination Are Both Route And Vector Dependent.

12:15 PM - 12:30 PM

Abstract

Biography

Chair

David O'Connor
Professor
University Of Wisconsin - Madison

Charani Ranasinghe
ANU

loading